Epidemiological data show that the increased levels of platelet activation biomarkers, activation of glycoprotein IIb‐IIIa complex and P‐selectin, are significantly related to cognitive decline in AD patients (Stellos et al., 2010). The gene discussed is SELP; the disease is Alzheimer disease.